Fund Twenty8 is no longer open to new investments. Please visit our Access EIS Fund page if you wish to make an investment.
Fund Twenty8 follows the decisions of sophisticated private and professional investors to automatically build you a diversified portfolio of no fewer than 28 EIS-qualifying startups.
The fund’s strategy is based on extensive research conducted by NESTA and Intelligent Partnership, which asked the question: how many startup investments should I have?
The magic number appears to be: no fewer than 28. With this many startups in your portfolio, the study suggests a 95% chance of at least one giving you a return of 10X or more. With this in mind, the fund is targeting a return of over 20% IRR, including up to 30% EIS tax relief.
{% youtube cAyo9Tc2yew %}
{% fullWidth grey--title %}
Fund Twenty8 received an independent review from MJ Hudson Allenbridge, a leading independent investment advisory and investment research group, providing independent advice, due diligence and analytical solutions to help institutional investors make better investment decisions.
This independent review has not been commissioned by SyndicateRoom. It has not been issued or approved by SyndicateRoom. It is not a recommendation to invest and does not constitute advice.
<a href=""https://files.syndicateroom.com/fund-docs/f28iv-allenbridgereview.pdf"" class="button-link">
<a href=""https://files.syndicateroom.com/fund-docs/f28iv-rating-certificate-allenbridge.pdf"" class="button-link">
{% endfullWidth %}
While traditional EIS funds normally invest in just a few companies, covering limited sectors, Fund Twenty8 backs a minimum of 28 per fund, per year, offering truly sector-agnostic diversification.
Having just finished deploying its second fund, Fund Twenty8 has:
{% blockquote-img "/images/f28-suraj-rajan.jpg" "Suraj" "Rajan" "Fund Twenty8 investor" %}
I’ve been investing in individual companies and have built up a sizeable portfolio, but I’d not invested in EIS funds until I discovered Fund Twenty8.
The focus on diversification makes a lot of sense to me and I think that using the personal investment decisions of numerous savvy investors to deploy capital is a very clever model.
{% endblockquote-img %}
{% endfullWidth %}
PORTFOLIO BREAKDOWN
By following the investment decisions of some of the savviest private investors, Fund Twenty8 automatically builds you a diversified portfolio of no fewer than 28 EIS-qualifying startups. The portfolio of every iteration of Fund Twenty8 will be added to this page as they finish deploying.
{% youtube rBJYbCV8yJ0 %}
{% fullWidth grey--title %}
Fund Twenty8''s 2017 portfolio consists of 32 investments spanning ten sectors. As our portfolio grows and raises further capital, we look forward to seeing its companies succeed.
Bockatech
ENGINEERING
Interpac
ENGINEERING
Greenspur Renewables
ENVIRONMENT
Naked Energy
ENVIRONMENT
Pass the Keys
MARKETPLACES
Pekama
MARKETPLACES
LuckyTrip
MARKETPLACES
Ambicare
LIFE SCIENCES
Arcis Biotechnology
LIFE SCIENCES
Cipher Surgical
LIFE SCIENCES
EnteroBiotix
LIFE SCIENCES
Gemetix Healthcare
LIFE SCIENCES
Molecular Warehouse
LIFE SCIENCES
MGB Biopharma
LIFE SCIENCES
Metrion Biosciences
LIFE SCIENCES
Lightpoint Medical
LIFE SCIENCES
PatientSource
LIFE SCIENCES
Pertinax Pharma
LIFE SCIENCES
Supapass
MEDIA
NextUp Comedy
MEDIA
AskIf
FINANCIAL
Cambscuisine
OTHER
Cyance
SOFTWARE
Driftrock
SOFTWARE
Liopa
SOFTWARE
Measurematch
SOFTWARE
infloAi
SOFTWARE
Kulea
SOFTWARE
Sensize
SOFTWARE
2Mee
SOFTWARE
Mayku
TECH
Mimica
TECH
{% endfullWidth %}
The first Fund Twenty8 closed in 2017 and finished deploying in 2018. By September, the portfolio was valued at 108% (paper value). Its final portfolio is a testament to the fund''s mission: to deliver investors a large and diversified portfolio of at least 28 investments.
Dymag
ENGINEERING
Alert Technology
ENVIRONMENT
USIO
ENVIRONMENT
Pekama
MARKETPLACES
Starstock
MARKETPLACES
Celame
MARKETPLACES
Biotechspert
MARKETPLACES
Make it Social
MARKETPLACES
e-Patient Network
HEALTHCARE
Dem DX
HEALTHCARE
Emoquo
HEALTHCARE
SupaPass
MEDIA
Peptinnovate
PHARMA
Re-Vana Therapeutics
PHARMA
Digital Therapeutics
PHARMA
Camallergy
PHARMA
Momentum Bioscience
PHARMA
FutureYou
PHARMA
Metrion Biosciences
PHARMA
Arcis
PHARMA
Redecol
MEDTECH
Warwick Analytics
SOFTWARE
Articheck
SOFTWARE
Brytlyt
SOFTWARE
Fantoo
SOFTWARE
10to8
SOFTWARE
Cyance
SOFTWARE
TenderSpace
SOFTWARE
Warwick Audio
TECH
Freedom One
TECH
Shields Energy
TECH
Engenie
TRANSPORT
{% endfullWidth %}